Literature DB >> 23552122

Dietary iron restriction prevents further deterioration of renal damage in a chronic kidney disease rat model.

Yoshiro Naito1, Aya Fujii, Hisashi Sawada, Shinichi Hirotani, Toshihiro Iwasaku, Yoshitaka Okuhara, Akiyo Eguchi, Mitsumasa Ohyanagi, Takeshi Tsujino, Tohru Masuyama.   

Abstract

OBJECTIVE: Iron accumulation is associated with the pathogenesis of chronic kidney disease (CKD). However, little is known about the effects of isolated iron restriction against CKD. We have recently reported that iron restriction prevents the development of renal damage in the well established 5/6 nephrectomy rat model of CKD. Herein, we investigated the therapeutic effects of iron restriction on preexisting hypertension and renal damage in a rat model of CKD.
METHODS: CKD was induced by 5/6 nephrectomy in Sprague-Dawley rats. After surgery, 5/6 nephrectomized rats were given an iron-restricted diet from 1 day to 16 weeks for prevention protocol or from 8 to 16 weeks for rescue protocol. Other CKD rats were given a normal diet.
RESULTS: At 16 weeks after surgery, CKD rats developed hypertension and renal damage. Early intervention with iron restriction prevented the development of hypertension and vascular remodeling. By contrast, late intervention with iron restriction did not remarkably ameliorate preexisting hypertension and vascular remodeling in CKD rats. On the contrary, late intervention with iron restriction prevented further progression of preexisting renal damage in CKD rats. Interestingly, iron restriction led to increased urinary sodium and decreased urinary potassium excretions in CKD rats. Moreover, iron restriction markedly attenuated renal expression of nuclear mineralocorticoid receptor and Rac1 activity in CKD rats.
CONCLUSION: Iron restriction prevented further deterioration of preexisting renal damage. The beneficial effects of iron restriction on renal damage seem to be associated with inhibition of renal mineralocorticoid receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23552122     DOI: 10.1097/HJH.0b013e328360381d

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  16 in total

1.  Attenuation of hypertension and renal damage in renovascular hypertensive rats by iron restriction.

Authors:  Makiko Oboshi; Yoshiro Naito; Hisashi Sawada; Toshihiro Iwasaku; Yoshitaka Okuhara; Akiyo Eguchi; Shinichi Hirotani; Toshiaki Mano; Takeshi Tsujino; Tohru Masuyama
Journal:  Hypertens Res       Date:  2016-07-21       Impact factor: 3.872

2.  Possible therapeutic impact of the iron chelation on renal fibrosis.

Authors:  Kouichi Tamura; Kazushi Uneda; Kengo Azushima; Hiromichi Wakui; Kotaro Haruhara
Journal:  Hypertens Res       Date:  2015-04-16       Impact factor: 3.872

3.  Novel insights into renovascular hypertension and cardio-renal protection by iron restriction.

Authors:  Atsushi Tanaka; Koichi Node
Journal:  Hypertens Res       Date:  2016-09-08       Impact factor: 3.872

4.  Acute and Chronic Iron Overloading Differentially Modulates the Expression of Cellular Iron-homeostatic Molecules in Normal Rat Kidney.

Authors:  Bassem Refaat; Abdelghany Hassan Abdelghany; Mohammad A BaSalamah; Mohamed El-Boshy; Jawwad Ahmad; Shakir Idris
Journal:  J Histochem Cytochem       Date:  2018-06-06       Impact factor: 2.479

5.  Association between renal iron accumulation and renal interstitial fibrosis in a rat model of chronic kidney disease.

Authors:  Yoshiro Naito; Aya Fujii; Hisashi Sawada; Makiko Oboshi; Toshihiro Iwasaku; Yoshitaka Okuhara; Daisuke Morisawa; Akiyo Eguchi; Shinichi Hirotani; Tohru Masuyama
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

6.  Iron restriction inhibits renal injury in aldosterone/salt-induced hypertensive mice.

Authors:  Hisashi Sawada; Yoshiro Naito; Makiko Oboshi; Toshihiro Iwasaku; Yoshitaka Okuhara; Daisuke Morisawa; Akiyo Eguchi; Shinichi Hirotani; Tohru Masuyama
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

7.  Dysregulation of the sensory and regulatory pathways controlling cellular iron metabolism in unilateral obstructive nephropathy.

Authors:  James A Votava; Shannon R Reese; Kathryn M Deck; Christopher P Nizzi; Sheila A Anderson; Arjang Djamali; Richard S Eisenstein
Journal:  Am J Physiol Renal Physiol       Date:  2021-11-29

Review 8.  The Cross-Link between Ferroptosis and Kidney Diseases.

Authors:  Jingyu Wang; Yi Liu; Yaqing Wang; Li Sun
Journal:  Oxid Med Cell Longev       Date:  2021-05-03       Impact factor: 6.543

9.  Iron-restricted pair-feeding affects renal damage in rats with chronic kidney disease.

Authors:  Yoshiro Naito; Aya Senchi; Hisashi Sawada; Makiko Oboshi; Tetsuo Horimatsu; Keisuke Okuno; Seiki Yasumura; Masaharu Ishihara; Tohru Masuyama
Journal:  PLoS One       Date:  2017-02-14       Impact factor: 3.240

10.  Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction.

Authors:  Yasumasa Ikeda; Iori Ozono; Soichiro Tajima; Mizuki Imao; Yuya Horinouchi; Yuki Izawa-Ishizawa; Yoshitaka Kihira; Licht Miyamoto; Keisuke Ishizawa; Koichiro Tsuchiya; Toshiaki Tamaki
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.